Effect of a Collaborative Care Intervention vs Usual Care on Health Status of Patients With Chronic Heart Failure: The CASA Randomized Clinical Trial

JAMA Internal Medicine
David B BekelmanPaula Meek

Abstract

Many patients with chronic heart failure experience reduced health status despite receiving conventional therapy. To determine whether a symptom and psychosocial collaborative care intervention improves heart failure-specific health status, depression, and symptom burden in patients with heart failure. A single-blind, 2-arm, multisite randomized clinical trial was conducted at Veterans Affairs, academic, and safety-net health systems in Colorado among outpatients with symptomatic heart failure and reduced health status recruited between August 2012 and April 2015. Data from all participants were included regardless of level of participation, using an intent-to-treat approach. Patients were randomized 1:1 to receive the Collaborative Care to Alleviate Symptoms and Adjust to Illness (CASA) intervention or usual care. The CASA intervention included collaborative symptom care provided by a nurse and psychosocial care provided by a social worker, both of whom worked with the patients' primary care clinicians and were supervised by a study primary care clinician, cardiologist, and palliative care physician. The primary outcome was patient-reported heart failure-specific health status, measured by difference in change scores on the Ka...Continue Reading

Citations

Jan 9, 2019·The Cochrane Database of Systematic Reviews·Andrea TakedaStephanie Jc Taylor
Jan 17, 2019·European Heart Journal. Quality of Care & Clinical Outcomes·Kelsey M FlintDavid B Bekelman
Mar 22, 2019·Western Journal of Nursing Research·Macy L StockdillMarie Bakitas
Oct 24, 2019·Journal of Palliative Medicine·Natalie C ErnecoffDio Kavalieratos
Jan 3, 2020·Current Opinion in Supportive and Palliative Care·Arden O'DonnellVickie Leff
Dec 14, 2019·Current Opinion in Cardiology·Michael J DiamantMustafa Toma
Dec 7, 2019·Journal of Palliative Medicine·Karen HydenHeather Coats
May 1, 2020·Circulation·Connie White-WilliamsUNKNOWN American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Epid
Sep 3, 2020·Current Heart Failure Reports·Savitri Fedson
Jun 27, 2019·The New England Journal of Medicine·Haider J Warraich, Diane E Meier
Jun 12, 2020·Journal of Palliative Medicine·Lyndsay DeGrootMartha Abshire
Nov 23, 2018·The American Journal of Hospice & Palliative Care·Deborah M PriceBidisha Ghosh
Sep 10, 2020·Circulation. Heart Failure·Yuchieh Kathryn ChangDavid Hui
Dec 4, 2019·Current Heart Failure Reports·Sarah ChuziHaider J Warraich
Nov 29, 2020·Epilepsy & Behavior : E&B·Benzi M KlugerMark Spitz
Feb 9, 2021·Journal of Pain and Symptom Management·Rachel WellsMarie Bakitas
Feb 27, 2021·Frontiers in Cardiovascular Medicine·Piotr Z SobanskiSarah J Goodlin
Jun 6, 2020·Mayo Clinic Proceedings·Mandeep SinghMohammed A Al-Hijji
Mar 18, 2021·Social Work in Health Care·Kamal WagleDebra K Litzelman
Mar 30, 2021·Circulation Journal : Official Journal of the Japanese Circulation Society·Toshihisa AnzaiUNKNOWN Japanese Circulation Society Joint Working Group
May 25, 2021·CJC Open·Michael J BonaresKirsten Wentlandt
May 22, 2021·Journal of Pain and Symptom Management·Lubin R DengDavid B Bekelman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.